Bio-Rad Laboratories, Inc.
BIO Healthcare Medical Devices
Bio-Rad Laboratories, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $2.6 billion, up 0.65% from fiscal 2024.
- Revenue
- +0.52%
- EPS
- +234.9%
- Free cash flow
- +8.07%
- Total debt
- +0.11%
Quarter to September 2026, against a year earlier
Follow BIO
Alert me
Bio-Rad Laboratories, Inc. (BIO) Operating margin
Bio-Rad Laboratories, Inc.'s operating margin over the twelve months to 30 September 2026 was −2.39%, down 4.2 percentage points from fiscal 2025 (1.83%). Over the past ten years it has ranged from −4.51% (fiscal 2018) to 17.2% (fiscal 2022); the current reading is higher than 18% of that period. That is above the Medical Devices industry median of −15.1% and below the Healthcare sector median of 0.00%.
Operating margin, annual
Embed this chart
Annual newest first
| Period | Operating margin | Change (points) |
|---|---|---|
| FY2025 | 1.83% | (8.65) |
| FY2024 | 10.5% | (2.17) |
| FY2023 | 12.7% | (4.57) |
| FY2022 | 17.2% | 0.10 |
| FY2021 | 17.1% | 0.57 |
| FY2020 | 16.6% | 6.62 |
| FY2019 | 9.93% | 14.44 |
| FY2018 | −4.51% | (10.03) |
| FY2017 | 5.52% | 2.83 |
| FY2016 | 2.69% | (5.57) |
Quarterly newest first
| Period | Operating margin | Change (points) |
|---|---|---|
| Sep 2026 | −7.57% | (18.72) |
| Jun 2026 | 11.2% | 5.39 |
| Mar 2026 | 5.76% | 22.91 |
| Dec 2025 | −17.2% | (27.15) |
| 43 more quarters | Free account |
Against its own ten years
Operating margin against peers
| Company | Operating margin |
|---|---|
| GMED Globus Medical, Inc. compare | 21.7% |
| PODD Insulet Corporation compare | 18.4% |
| PEN Penumbra, Inc. compare | 12.1% |
| SNN Smith & Nephew SNATS, Inc. compare | 0.00% |
| BRKR Bruker Corporation compare | −1.99% |
| BIO.B Bio-Rad Laboratories, Inc. compare | −2.39% |
| BIO Bio-Rad Laboratories, Inc. | −2.39% |
| TXG 10x Genomics compare | −14.3% |
| GKOS Glaukos Corporation compare | −25.5% |
| Medical Devices industry median | −15.1% |
| Healthcare sector median | 0.00% |
| Market median | 0.00% |
What Operating margin is
EBIT Margin tells an investor how much operating profit, before interest and taxes, a company keeps from each unit of revenue.
EBIT ÷ Revenue
More on BIO
- Revenue
- Net income
- EPS (diluted)
- EBITDA
- Free cash flow
- Operating cash flow
- Gross margin
- Net margin
- Free cash flow margin
- P/E ratio
- P/S ratio
- P/B ratio
- Price to free cash flow
- EV/EBITDA
- EV/Sales
- EV/FCF
- Return on equity
- Return on assets
- Return on invested capital
- Debt to equity
- Current ratio
- Total debt
- Shares outstanding
- Book value per share
- Revenue growth
- Piotroski F-score
- Altman Z-score
- Beneish M-score
- The full statement